Tirzepatide tablets price: what private treatment costs in the UK

Free clinical consultation included (no separate assessment fee
Prescription written and reviewed by a GPhC-registered Independent Prescriber, not an automated system
Same-day dispatch once approved (order by 12pm Monday–Friday), delivered free by DPD the next working day in plain packaging
7-day priority aftercare included) no bolt-on support fees, no subscription

There are no tirzepatide tablets licensed for weight management in the UK. Tirzepatide is available as a once-weekly injection, sold here under the brand name Mounjaro. UK private prices vary by dose and provider, and any legitimate price includes a prescription following clinical assessment. Here is how the costs actually break down — and what to watch for when comparing.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How tirzepatide (Mounjaro) is priced privately in the UK, and what that price should cover

Step 1: understand what you are actually being quoted

When you search for a tirzepatide price online, the number you see is usually for a single Mounjaro KwikPen. Each pen contains four weekly doses, so one pen covers roughly one month of treatment. Prices across the private market have shifted considerably since Eli Lilly revised their UK list price in September 2025: at the highest dose, the manufacturer's list price rose from around £122 to around £330 per pen, and typical private prices since then have ranged roughly £149 to £375 per month depending on dose and provider, as widely reported at the time.

Those numbers are a useful reference point. Treatment begins at the 2.5mg dose — not because it produces significant weight loss at that level, but because starting low lets your system adjust before the prescriber moves you up through the schedule. So the monthly cost changes as your dose changes. If you want to understand what you might pay at that opening stage, the tirzepatide 5mg price page breaks down costs specific to the starter and early doses. A quote for the starter pen looks very different from a quote for the 15mg maintenance pen, and neither figure tells you the full story without knowing what else is included.

For a fuller breakdown of how costs stack up across the dose ladder, the tirzepatide cost guide covers each stage of the schedule in detail.

Step 2: check what the headline price leaves out

A low advertised figure often excludes several things a patient reasonably expects to be covered. Consultation fees are charged separately by some providers. Prescription fees, delivery charges and ongoing clinical reviews can each add to the real total. Aftercare (being able to speak to a clinician if you experience side effects or have questions between doses) is not always part of the package.

This matters because Mounjaro is a Prescription-Only Medicine (POM). Under UK law it can only be supplied following a clinical assessment by a qualified prescriber. That assessment is not optional administrative overhead; it is the mechanism that keeps the medicine safe and legal. NICE's appraisal of tirzepatide (TA1026) sets out the clinical framework within which it should be used. A price that strips out the clinical infrastructure to look competitive is doing so at a cost the patient ends up bearing, in money or in risk.

Delivery is another variable. Mounjaro requires refrigeration, so the courier method and cold-chain handling matter. A pen that arrives at ambient temperature after sitting in a collection locker is not equivalent to one dispatched same-day in temperature-appropriate packaging.

Step 3: see what an all-in price looks like at nume

nume does not compete on having the lowest number. That is a deliberate choice. One transparent price covers the consultation, the prescription, the medicine, and free next-working-day delivery, there are no add-ons and no subscription that auto-renews. The current treatment pricing is shown on the weight-loss treatments page; we do not print per-pen prices in body copy because those figures shift and the full context matters more than a number in isolation.

Every repeat order goes back to a prescriber for clinical review before anything is dispensed. A named GPhC-registered Independent Prescriber reads your consultation, that is the standard our clinical team holds to on every order. Our pharmacy is GPhC-registered (premises number 9012878, verifiable on the GPhC register), and medicines come through the licensed UK supply chain. If you order by midday, your pen leaves the same day. It typically arrives with DPD the next working day, you get the tracking link, not a mystery date.

If price is genuinely the deciding factor, that is understandable. But for context on how Mounjaro pricing compares across the range, the Mounjaro price guide has the detail.

Step 4: why the cheapest listing is the wrong answer to the right question

The real question behind a price search is usually: can I afford this, and is it worth it? Those are fair things to ask. The answer that keeps you safe, though, is not the lowest number you can find, it is whether the provider is registered, whether a real clinician assessed you, and whether the medicine you receive came through the authorised supply chain.

The MHRA has warned publicly about counterfeit weight-loss pens sold online: fake pens have been found to contain insulin rather than tirzepatide, with serious consequences for the people who used them. The MHRA's Yellow Card scheme lets you report suspect sellers directly. Red flags include pens offered without a clinical assessment, prices substantially below the current market range, and sellers operating through social media or unverifiable websites. Before you compare providers, it is worth reading the Mounjaro tablets price page and the tirzepatide tablet price page, which explain the tablet formulations now available and how their costs compare to the pen, so you have a complete picture of what is on the market. For a Prescription-Only Medicine, the cheapest listing answers the wrong question entirely.

The Mounjaro overview page covers eligibility, how the treatment works, and what the clinical evidence shows, useful reading before a consultation if you want the full picture. And if you have questions about anything covered here, the FAQs or our support team are straightforward ways to get them answered.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions